21st Century Cures and Off-Label Promotion Benefit HEOR and Drug Safety

As my writing for the AdverseEvents Blog can attest, I’m in favor of data transparency. In my view, no organization should have monopolistic control over important information that limits the ability for healthcare decision makers to perform unbiased, objective comparative… Continue Reading

Adding value to biomedical endpoints – The Importance of Patient Reported Outcomes (PROs)

The challenges A key hurdle facing the entire pharmaceutical industry is non-adherence by patients to medication. This problem is only likely to be surmounted if patients believe that taking medication will lead to immediate benefits through reduction of symptoms, improvement… Continue Reading